Vistin Pharma ASA
12.2.2021 14:31:32 CET | Globenewswire | Press release
Oslo, Norway, 12 February 2020
Vistin Pharma ASA will release its fourth quarter 2020 results on Friday 19th of February 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 19th of February at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in Norwegian.
The fourth quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:........ 3067548
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/c6wg4zco
****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Pardu Productions Limited12.9.2026 13:55:18 CEST | Press release
Pardu Productions Publishes Exclusive Feature on Marc Mysterio's Proposed “Name vs. Name” Match
Circle Cardiovascular Imaging Inc.11.9.2026 23:00:00 CEST | Press release
Circle Cardiovascular Imaging Ready to Help Heart Teams Meet the Next Era of TAVR as CMS Finalizes Expanded Medicare Coverage
Beijing Perfect World Software Technology Development Co., Ltd.11.9.2026 22:45:56 CEST | Press release
“BEYOND THE EXTREME" Digital Music Night Debuts at ICEBAR Stockholm
Frontline plc.11.9.2026 22:30:00 CEST | Press release
FRO – Declares special one-time dividend after sale of two VLLCs
Orion Oyj11.9.2026 18:00:00 CEST | Press release
Orion Corporation: Acquisition of own shares during week 37, 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
